Abstract: A display apparatus including a display and a supporter. The supporter being mounted on the display and configured to support the display and rotate the display module between a first position and a second position. The supporter including a drive motor, a first gear, and a detection sensor. The drive motor configured to supply a driving force to rotate the display. The first gear configured to rotate together with the display by receiving the driving force from the drive motor. The detection sensor configured to detect a rotation amount of a second gear configured to rotate in with the first gear.

Abstract: A display device includes a display unit including pixels connected to data lines and scan lines, first and second temperature sensors for sensing first and second temperatures of the display unit, a data driver configured to generate a data signal configured to be supplied to the data lines using output data, and attached to a first printed circuit board configured to be fixed to a rear surface of the display unit, a timing controller configured to generate the output data using input data, and attached to a second printed circuit board configured to be fixed to the rear surface of the display unit, and a storage having a temperature weight table including a weight corresponding to the first and second temperatures and a plurality of temperature tables including temperature information of the display unit corresponding to an attachment position of the second printed circuit board.

Abstract: One embodiment of the present specification provides a siloxane compound represented by Chemical Formula 1 below: In Chemical Formula 1, R1a and R1b are each independently a substituted or unsubstituted straight or branched-chain alkyl group having 1 to 16 carbon atoms, R2a and R2b are each independently a substituted or unsubstituted straight or branched-chain alkyl group having 1 to 16 carbon atoms, R3a and R3b are each independently a substituted or unsubstituted straight or branched-chain alkylene group having 1 to 16 carbon atoms, R4a, R4b, R5a, and R5b are each independently hydrogen, a substituted or unsubstituted straight or branched alkyl group having 1 to 16 carbon atoms, or a substituted or unsubstituted straight or branched-chain heteroalkyl group having 1 to 16 carbon atoms, m1 and m2 are each an integer from 0 to 2, and when m1 and m2 are each 0, a plurality of OR2a and OR2b are the same or different, and when m1 and m2 are each 2, a plurality of R1a and R1b are the same or different, and x

Abstract: A display apparatus including a display and a supporter. The supporter being mounted on the display and configured to support the display and rotate the display module between a first position and a second position. The supporter including a drive motor, a first gear, and a detection sensor. The drive motor configured to supply a driving force to rotate the display. The first gear configured to rotate together with the display by receiving the driving force from the drive motor. The detection sensor configured to detect a rotation amount of a second gear configured to rotate in with the first gear.

Abstract: The present disclosure provides metal nanoparticles for glucose detection, including: metal nanoparticles with glucose oxidase attached; and a cell membrane isolated from erythrocytes, which surrounds the metal nanoparticles, and a glucose detection method using the same.

Abstract: Disclosed are a colorimetric sensor kit for screening a therapeutic agent for a neurodegenerative disease, capable of easily detecting the degradation of amyloids by a drug, and a method for screening a therapeutic agent for a neurodegenerative disease.

Abstract: Provided is a biomaterial detection sensor. The biomaterial detection sensor comprises a substrate and a detection probe including a metal nanoparticle deposited on the substrate, and an erythrocyte membrane conformally covering the metal nanoparticle, wherein the detection probe may selectively react with fibrinogen.

Abstract: The present disclosure provides metal nanoparticles for glucose detection, including: metal nanoparticles with glucose oxidase attached; and a cell membrane isolated from erythrocytes, which surrounds the metal nanoparticles, and a glucose detection method using the same.

Abstract: The present disclosure relates to a biosensor for measuring glucose in a biological sample, which contains a filter unit formed of a cytoplasmic membrane, which allows selective permeation of glucose in a biological sample. The biosensor of the present disclosure, which contains the cytoplasmic membrane filter unit allowing selective permeation of glucose in the biological sample, exhibits high glucose detection sensitivity as compared to the commercially available blood sugar measuring sensors and also exhibits high glucose detection specificity despite the addition of signal-interfering substances such as fructose, xylose, maltose, cysteine, ascorbic acid, uric acid, galactose, etc. In addition, because he cytoplasmic membrane filter unit contained in the biosensor for measuring glucose of the present disclosure is not significantly affected by the moisture in the air, it can be applied to various products such as a disposable blood sugar test strip or an attachable or implantable glucose measuring device.

Abstract: The present disclosure relates to a method for measuring fibrinogen concentration in a blood sample, which enables measuring of the concentration of the fibrinogen protein present in a blood sample from the human body. The method for measuring fibrinogen concentration of the present disclosure is convenient because an enzyme is not used. In addition, an error due to a factor affecting factor affecting in-vivo enzyme activity does not occur and measuring time is decreased since measurement for reference plasma is unnecessary. Therefore, the method achieves superior accuracy, precision and reproducibility as compared to the existing technologies and can be usefully employed for measuring fibrinogen concentration in a blood sample.

Abstract: Disclosed is a method for determining malignant melanoma by a scanning probe microscope system with a cantilever, which includes: setting locations of a plurality of measurement points to be measured in a sample tissue; applying force in a predetermined range to each measurement point on the sample tissue through the cantilever and acquiring information on a distance between a probe and the sample tissue depending on force for each measurement point; generating a force-distance graph of measurement points based on distance information depending on the force acquired at the plurality of measurement points; and determining whether the sample tissue is malignant melanoma based on characteristics information of the sample tissue extracted from the force-distance graph.

Abstract: The present disclosure relates to a biosensor for measuring glucose in a biological sample, which contains a filter unit formed of a cytoplasmic membrane, which allows selective permeation of glucose in a biological sample. The biosensor of the present disclosure, which contains the cytoplasmic membrane filter unit allowing selective permeation of glucose in the biological sample, exhibits high glucose detection sensitivity as compared to the commercially available blood sugar measuring sensors and also exhibits high glucose detection specificity despite the addition of signal-interfering substances such as fructose, xylose, maltose, cysteine, ascorbic acid, uric acid, galactose, etc. In addition, because he cytoplasmic membrane filter unit contained in the biosensor for measuring glucose of the present disclosure is not significantly affected by the moisture in the air, it can be applied to various products such as a disposable blood sugar test strip or an attachable or implantable glucose measuring device.

Abstract: The present invention relates to a biosensor specifically detecting a protein kinase A (PKA), and a diagnosis kit comprising the biosensor. In particular, the present invention relates to a biosensor for detecting a PKA comprising a cantilever, and a protein kinase inhibitor (PKI) immobilized on the surface of the cantilever; and a kit for diagnosing diseases caused by the increase of the activity of a protein kinase, comprising a sample, the biosensor, and a quantification manner.

Abstract: Disclosed are system and method for measuring a bio-element capable of accurately detecting whether a bio-element such as protein, gene and the like is present in an atmosphere or vapor phase having controlled temperature and humidity thereof and measuring a content of the bio-element. According to an embodiment of the invention, the method comprises steps of preparing a cantilever sensor having a plurality of cantilevers; measuring a basis resonant frequency for the plurality of cantilevers; reacting the cantilevers with a sample including a bio-element; measuring resonant frequencies of the cantilevers after the reaction, in a closed system that is isolated from an exterior environment and temperature and humidity thereof are controlled to a specific state; and calculating variations of the resonant frequencies of the cantilevers before and after the reaction to carry out a quantitative analysis of the bio-element included in the sample.

Abstract: The present invention relates to a biosensor specifically detecting a protein kinase A (PKA), and a diagnosis kit comprising the biosensor. In particular, the present invention relates to a biosensor for detecting a PKA comprising a cantilever, and a protein kinase inhibitor (PKI) immobilized on the surface of the cantilever; and a kit for diagnosing diseases caused by the increase of the activity of a protein kinase, comprising a sample, the biosensor, and a quantification manner.

Abstract: A method for detecting a polymerase chain reaction (PCR) product is provided. The method includes (a) providing at least a pair of electrodes in a PCR solution-containing vessel; (b) performing PCR; (c) producing an electric field between the electrodes; and (d) measuring a change in a dielectric property in the PCR solution. Therefore, a PCR product can be detected in real time.

Abstract: A method and sensor are provided for detecting the binding of a probe and a target biomolecule by measuring a difference in the shear stress on the surface of the sensor before and after hybridization of the target molecule to the probe, such as nucleic acids or proteins. The shear stress may be measured sensitively and conveniently as an electrical signal without additional fluorescent labeling and without use of expensive additional devices.

Abstract: Provided are a temperature control method and apparatus for driving a polymerize chain reaction (PCR) chip. In the temperature control apparatus, which is for a polymerize chain reaction chip, PCR chips receive electric power from the outside and generating heat to maintain a predetermined temperature and for outputting actual temperature information to the outside. electric power supply units supply electric power to the PCR chips according to input control signals, and a controller generates the control signals based on control information including pre-established control temperature and control time information and the actual temperature information supplied from the PCR chips in order to supply the control signals to the electric power supply units. In the present invention, it is possible to examine various kinds of DNA at the same time because the temperature control apparatus controls the temperatures of DNA samples at the same time.

Abstract: The present invention provides an apparatus for amplifying a polynucleotide, comprising a substrate, a microflow channel system disposed in the substrate and comprising a sample inlet port, a sample flow channel extending from the sample inlet port, and a polynucleotide polymerization reaction chamber in fluid communication with the sample flow channel, a first insulation groove formed around the reaction chamber, and a means for regulating a temperature of the reaction chamber. Accordingly, a multiple chamber device for amplifying a polynucleotide, comprising multiple polymerization reaction chambers formed in a substrate can be manufactured.

Abstract: A polymerase chain reaction (PCR) device with micro-valves, which are opened or closed using a simple control mechanism is provided. The PCR device includes: an inlet through which a biochemical fluid is injected; an outlet through which the biochemical fluid is discharged; a PCR channel positioned between the inlet and the outlet; first and second micro-valves, which control opening and closing of the inlet and the outlet; and a sol-gel transformable material, which transforms from a sol state into a gel state at a temperature lower than DNA denaturation temperature, annealing temperature and extension temperature and higher than room temperature.